Zobrazeno 31 - 40
of 69
pro vyhledávání: '"39"'
Autor:
Takahiko Horiuchi, Koichi Akashi, Mitsuteru Akahoshi, Hiroki Mitoma, Kensuke Irino, Yasutaka Kimoto, Shotaro Kawano, Masahiro Ayano, Yojiro Arinobu, Hiroaki Niiro
Publikováno v:
Lupus. 30:1637-1643
Objective The number of pregnant and delivery cases in systemic lupus erythematosus (SLE) patients are increasing due to the advances in therapies. However, there are many problems such as the exacerbation of SLE during pregnancy and the risk of feta
Publikováno v:
Lupus. 28:1302-1311
Objective To describe the clinical and radiological characteristics and outcomes of patients with aquaporin-4-immunoglobulin G (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with systemic lupus erythematosus (SLE) a
Autor:
Karin L G Svenson, Mustafa Al-Maini, Huda A. Al-Mohri, John D. Mountz, E. M. El-Ageb, Bazdawi M. Al-Riyami, Tong Zhou, Elizabeth R. Richens
Publikováno v:
Lupus. 9(2)
Objective: To evaluate whether the levels of soluble form of the Fas apoptosis antigen (sCD95=sFas) varied from those of healthy control subjects in a group of patients with systemic lupus erythematosus (SLE). This was done to determine whether sFas
Autor:
Rajesh Kumar, Ilaria Cavazzana, C Pozzari, R. Ottaviani, Angela Tincani, Franco Franceschini, Silvia Piantoni, Laura Andreoli, M. Fredi
Publikováno v:
Lupus. 28:1074-1081
Objective The objective of this study was to analyse autoantibodies’ titres modulation during belimumab treatment in 50 patients with systemic lupus erythematosus (SLE). Methods Sera were collected at belimumab start (T0) and every six months until
Autor:
Qian Wang, Jinmei Su, Xuejun Zeng, Shangzhu Zhang, Dong Wu, Ming Li, Jieqiong Li, Ziqian Wang, Jiuliang Zhao, Yongyan Wang, Dong Xu
Publikováno v:
Lupus. 29(4)
Objective This study aimed to identify the clinical characteristics and prognostic factors of systemic lupus erythematosus with transverse myelitis (SLE-TM) in a relatively large patient series. Methods This retrospective study considered 45 SLE-TM i
Publikováno v:
Lupus. 26:88-94
Objectives Antiphospholipid antibodies (aPL) are present in a proportion of patients with rheumatoid arthritis but their clinical significance remains unclear. We investigated the association between aPL and thrombotic events in rheumatoid arthritis
Autor:
V. Le Guern, Luc Mouthon, M Bonjour, J-C Piette, Nathalie Morel, Nathalie Costedoat-Chalumeau, C. Le Jeunne
Publikováno v:
Lupus. 24:1479-1485
Objectives Pericardial involvement is a frequent manifestation of systemic lupus erythematosus (SLE). Growing evidence suggests that colchicine may be useful for acute or recurrent pericarditis. We report for the first time a series of 10 consecutive
Publikováno v:
Lupus. 23(7)
Background Antiphospholipid syndrome (APS) is an autoimmune hypercoagulable disorder that has been shown to cause a large number of cardiac and neurological manifestations. Two recent studies have demonstrated abnormalities in cardiovascular autonomi
Publikováno v:
Lupus. 20(8)
Disease activity 6 months before pregnancy of patients with systemic lupus erythematosus (SLE) associated with adverse maternal and fetal outcomes is not well studied. The aim of the study was to identify predictors of adverse maternal and fetal outc
Publikováno v:
Lupus. 18(4)
We report the clinicopathological features, treatment and outcome of 54 Indian children (14 boys) with biopsy-proven lupus nephritis followed over a 10-year period. The mean age (SD) at onset of disease was 9.6 ± 2.6 (range 2.5–14.4) years. Twenty